Related Experiment Videos

Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway

Pushkar Sharma1, Veeranna, Monica Sharma

  • 1Laboratory of Neurochemistry, NINDS, National Institutes of Health, Bethesda, Maryland 20892, USA.

Insights

Cyclin-dependent protein kinase 5 (cdk5) inhibits the MAP kinase kinase-1 (MEK1) pathway, impacting neuronal development. This study reveals cdk5

Area of Science:

  • Neuroscience
  • Cell Biology
  • Molecular Biology

Background:

  • Cyclin-dependent protein kinase 5 (cdk5) is crucial for neuronal development and function.
  • The mitogen-activated protein (MAP) kinase pathway regulates various cellular processes.

Purpose of the Study:

  • To investigate the cross-talk between cdk5 activity and the MAP kinase pathway.
  • To elucidate the role of cdk5 in regulating MEK1 and ERK1/2 activity.

Main Methods:

  • In vivo and in vitro phosphorylation assays using cdk5 and MEK1.
  • Analysis of p35 (cdk5 activator) knockout mice.
  • Site-directed mutagenesis of MEK1 phosphorylation sites.

Main Results:

  • Cdk5 phosphorylates and inhibits MEK1 activity, consequently reducing ERK1/2 phosphorylation.
  • p35-/- mice exhibit increased MEK1 and ERK1/2 activity.
  • Mutation of Thr286 in MEK1 abolishes cdk5-mediated inhibition, identifying it as a key regulatory site.

Conclusions:

  • Cdk5 negatively regulates the MAP kinase pathway by phosphorylating MEK1 at Thr286.
  • This cross-talk is essential for proper neuronal function and development.
  • A model for feedback down-regulation of the MAP kinase pathway by cdk5 is proposed.

Related Concept Videos